Access Pharmaceuticals
About Us
Board of Directors
Senior Management
Product Programs
MuGard
Fact Sheet
MuGard.com
Order Form
ProLindac
Chemistry
Preclinical data
Future Development
Cobalamin mediated oral drug delivery
Thiarabine
CobaCyte - Cobalamin targeted delivery
Publications
Business Development
Investor Relations
Newsroom
2011
2010
2009
Contact Us
Product Programs
MuGard
ProLindac
Cobalamin mediated oral drug delivery
Thiarabine
CobaCyte - Cobalamin targeted delivery
Publications
Contact
2600 Stemmons Freeway,
Suite 176
Dallas, TX 75207-2107
Tel: (214) 905-5100
Fax: (214) 905-5101
info@accesspharma.com
Sign up for news alerts!
Product Pipeline
Sign up for news alerts!
Latest Product Programs News & Events
12.07.11
MUGARD ADVOCATE INTERVIEWED ON ABC TAMPA NEWS AT NOON
11.15.11
Access Pharmaceuticals Provides Third Quarter Update on MuGard Commercial Activities
10.14.11
Access Pharmaceuticals Updates MuGard Website with New Video Featuring Clinical Feedback and Manufacturing Footage
10.13.11
Access Pharmaceuticals Provides Update on Increasing Payer Uptake for MuGard
09.28.11
Access Pharmaceuticals Reports Additional MuGard Study Findings Presented at EMCC 2011 in Stockholm
More News